ABERCROMBIE & FITCH CO /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ABERCROMBIE & FITCH CO /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $5.27B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $4.95B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $4.28B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $3.70B | Mar 31, 2025 |
| FY2023 | Jan 29, 2022 | $3.71B | Apr 1, 2024 |
| FY2022 | Jan 30, 2021 | $3.13B | Mar 27, 2023 |
| FY2019 | Feb 1, 2020 | $1.18B | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | $863.47M | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | $841.08M | Mar 31, 2020 |
| FY2019 | May 4, 2019 | $733.97M | Mar 31, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Feb 2, 2019 | $1.16B | Apr 1, 2019 |
| FY2018 | Nov 3, 2018 | $861.19M | Apr 1, 2019 |
| FY2018 | Aug 4, 2018 | $842.41M | Apr 1, 2019 |
| FY2018 | May 5, 2018 | $730.90M | Apr 1, 2019 |
| FY2018 | Feb 3, 2018 | $1.19B | Apr 1, 2019 |
| FY2018 | Oct 28, 2017 | $859.11M | Apr 1, 2019 |
| FY2018 | Jul 29, 2017 | $779.32M | Apr 1, 2019 |
| FY2018 | Apr 29, 2017 | $661.10M | Apr 1, 2019 |
| FY2017 | Jan 28, 2017 | $1.04B | Apr 2, 2018 |
| FY2017 | Oct 29, 2016 | $821.73M | Apr 2, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Feb 3, 2024 | $2.69B | Apr 1, 2024 |
| FY2023 | Jan 28, 2023 | $2.10B | Apr 1, 2024 |
| FY2023 | Jan 29, 2022 | $2.31B | Apr 1, 2024 |
| FY2022 | Jan 30, 2021 | $1.89B | Mar 27, 2023 |
| FY2019 | Feb 1, 2020 | $689.26M | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | $518.93M | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | $498.63M | Mar 31, 2020 |
| FY2019 | May 4, 2019 | $444.09M | Mar 31, 2020 |
| FY2019 | Feb 2, 2019 | $682.86M | Mar 31, 2020 |
| FY2019 | Nov 3, 2018 | $527.82M | Mar 31, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $506.92M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $566.22M | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $328.12M | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $2.82M | Mar 31, 2025 |
| FY2023 | Jan 29, 2022 | $263.01M | Apr 1, 2024 |
| FY2021 | Jan 30, 2021 | ($114.02M) | Mar 28, 2022 |
| FY2019 | Feb 1, 2020 | $83.13M | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | $6.52M | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | ($31.14M) | Mar 31, 2020 |
| FY2019 | May 4, 2019 | ($19.16M) | Mar 31, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $699.14M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $740.82M | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $484.67M | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $92.65M | Mar 31, 2025 |
| FY2023 | Jan 29, 2022 | $343.08M | Apr 1, 2024 |
| FY2022 | Jan 30, 2021 | ($20.47M) | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $70.07M | Mar 28, 2022 |
| FY2020 | Feb 2, 2019 | $127.37M | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $72.05M | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $15.19M | Apr 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $619.14M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $710.38M | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $653.42M | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | ($2.34M) | Mar 31, 2025 |
| FY2023 | Jan 29, 2022 | $277.78M | Apr 1, 2024 |
| FY2022 | Jan 30, 2021 | $404.92M | Mar 27, 2023 |
| FY2020 | Oct 31, 2020 | $108.89M | Mar 29, 2021 |
| FY2020 | Aug 1, 2020 | $46.23M | Mar 29, 2021 |
| FY2020 | May 2, 2020 | ($140.78M) | Mar 29, 2021 |
| FY2021 | Feb 1, 2020 | $300.69M | Mar 28, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $240.77M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $182.90M | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $157.80M | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $164.57M | Mar 31, 2025 |
| FY2023 | Jan 29, 2022 | $96.98M | Apr 1, 2024 |
| FY2022 | Jan 30, 2021 | $101.91M | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $202.78M | Mar 28, 2022 |
| FY2020 | Feb 2, 2019 | $152.39M | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $107.00M | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $140.84M | Apr 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $3.54B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $3.30B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $2.97B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $2.71B | Mar 31, 2025 |
| FY2022 | Jan 29, 2022 | $2.94B | Mar 27, 2023 |
| FY2021 | Jan 30, 2021 | $3.31B | Mar 28, 2022 |
| FY2020 | Feb 1, 2020 | $3.55B | Mar 29, 2021 |
| FY2019 | Feb 3, 2019 | $3.56B | Mar 31, 2020 |
| FY2019 | Feb 2, 2019 | $2.39B | Mar 31, 2020 |
| FY2018 | Feb 3, 2018 | $2.33B | Apr 1, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.40B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $1.34B | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | $1.04B | Mar 31, 2025 |
| FY2023 | Jan 28, 2023 | $694.84M | Apr 1, 2024 |
| FY2022 | Jan 29, 2022 | $826.09M | Mar 27, 2023 |
| FY2021 | Jan 30, 2021 | $936.63M | Mar 28, 2022 |
| FY2020 | Feb 1, 2020 | $1.06B | Mar 29, 2021 |
| FY2019 | Feb 3, 2019 | $1.13B | Mar 31, 2020 |
| FY2019 | Feb 2, 2019 | $1.21B | Mar 31, 2020 |
| FY2019 | Feb 3, 2018 | $1.25B | Mar 31, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $3.70B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $3.20B | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | $2.64B | Mar 31, 2025 |
| FY2023 | Jan 28, 2023 | $2.37B | Apr 1, 2024 |
| FY2022 | Jan 29, 2022 | $2.39B | Mar 27, 2023 |
| FY2021 | Jan 30, 2021 | $2.15B | Mar 28, 2022 |
| FY2020 | Feb 1, 2020 | $2.31B | Mar 29, 2021 |
| FY2019 | Feb 3, 2019 | $2.34B | Mar 31, 2020 |
| FY2019 | Feb 2, 2019 | $2.42B | Mar 31, 2020 |
| FY2018 | Feb 3, 2018 | $2.42B | Apr 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $759.54M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $772.73M | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $900.88M | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $517.60M | Mar 31, 2025 |
| FY2023 | Jan 29, 2022 | $823.14M | Apr 1, 2024 |
| FY2022 | Jan 30, 2021 | $1.10B | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $671.27M | Mar 28, 2022 |
| FY2019 | Feb 3, 2019 | $723.14M | Mar 31, 2020 |
| FY2020 | Feb 2, 2019 | $723.14M | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $675.56M | Mar 31, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 10 | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | 11 | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | 6 | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Jan 29, 2022 | 4 | Apr 1, 2024 |
| FY2022 | Jan 30, 2021 | (1) | Mar 27, 2023 |
| FY2019 | Feb 1, 2020 | 1 | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | 0 | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | 0 | Mar 31, 2020 |
| FY2019 | May 4, 2019 | 0 | Mar 31, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 10 | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | 10 | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | 6 | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Jan 29, 2022 | 4 | Apr 1, 2024 |
| FY2022 | Jan 30, 2021 | (1) | Mar 27, 2023 |
| FY2019 | Feb 1, 2020 | 1 | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | 0 | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | 0 | Mar 31, 2020 |
| FY2019 | May 4, 2019 | 0 | Mar 31, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jan 28, 2023 | $0 | Mar 27, 2023 |
| FY2022 | Jan 29, 2022 | $0 | Mar 27, 2023 |
| FY2022 | Jan 30, 2021 | $12.56M | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $51.51M | Mar 28, 2022 |
| FY2020 | Feb 2, 2019 | $53.71M | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $54.39M | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $54.07M | Apr 1, 2019 |
| FY2017 | Jan 30, 2016 | $55.15M | Apr 2, 2018 |
| FY2016 | Jan 31, 2015 | $57.36M | Mar 27, 2017 |
| FY2015 | Feb 1, 2014 | $61.92M | Mar 28, 2016 |